Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy (Q34354300)

1 August 2017

1 reference

title

Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy (English)

1 reference

1 August 2017

angiogenesis inhibitor

1 reference

Jain RK

1

1 reference

PubMed ID

11533692

1 August 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

1 August 2017

1 reference

1 August 2017

7

1 reference

1 August 2017

9

1 reference

1 August 2017

987-989

1 reference

https://scigraph.springernature.com/pub.10.1038/nm0901-987

1 August 2017

0 references

cites work

The next frontier of molecular medicine: delivery of therapeutics.

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-987

7 January 2021

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-987

7 January 2021

Angiogenesis in cancer and other diseases

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-987

7 January 2021

A systems approach to cancer therapy. (Antioncogenics + standard cytotoxics-->mechanism(s) of interaction).

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-987

7 January 2021

Barriers to drug delivery in solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-987

7 January 2021

Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-987

7 January 2021

Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-987

7 January 2021

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-987

7 January 2021

Angiogenic heterogeneity: regulation of neoplastic angiogenesis by the organ microenvironment

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-987

7 January 2021

Targeting tumor vasculature with homing peptides from phage display

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-987

7 January 2021

Genes expressed in human tumor endothelium

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-987

7 January 2021

An antiangiogenic agent (TNP-470) inhibited reoxygenation during fractionated radiotherapy of murine mammary carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-987

7 January 2021

Identifiers

DOI

10.1038/NM0901-987

1 reference

1 August 2017

1 reference

PubMed ID

11533692